स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

grosse apotheke dr. g. bichsel ag - le glucose - solution à diluer pour perfusion - solvens (i.v.): glucosum 500 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 1000 ml. corresp. ca. 8370 kj. - glucose-therapie - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

gebro pharma ag - natrii chloridum, kalii chloridum, natrii citras dihydricus, glucosum - pulver zur herstellung einer lösung zum einnehmen im beutel - natrii chloridum 0.35 g, kalii chloridum 0.30 g, natrii citras dihydricus 0.59 g, glucosum 4.00 g, saccharinum natricum, aromatica golden syrup, aromatica tutti frutti cum alcohol benzylicus et propylenglycolum, silica colloidalis anhydrica, ad pulverem, pro charta corresp. natrium 276 mg, kalium 157 mg. - Électrolytes par voie orale de réhydratation - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum anhydricum, triglycerida, aminoacida, carbohydrata, materia crassa, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum, acetas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum dihydricum, natrii glycerophosphas, magnesii sulfas anhydricus, kalii chloridum, natrii acetas anhydricus, zinci sulfas anhydricus - infusionsemulsion - i) glucoselösung: glucosum anhydricum 125 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 298 ml. ii) aminosäurelösung mit elektrolyten: alaninum 7 g, argininum 6 g, glycinum 5.5 g, histidinum 1.5 g, isoleucinum 2.5 g, leucinum 3.7 g, lysinum anhydricum 3.3 g ut lysini acetas, methioninum 2.15 g, phenylalaninum 2.55 g, prolinum 5.6 g, serinum 3.25 g, taurinum 0.5 g, threoninum 2.2 g, tryptophanum 1 g, tyrosinum 0.2 g, valinum 3.1 g, calcii chloridum dihydricum 370 mg, natrii glycerophosphas 2.09 g, magnesii sulfas anhydricus 600 mg ut magnesii sulfas heptahydricus, kalii chloridum 2.24 g, natrii acetas anhydricus 1.7 g ut natrii acetas trihydricus, zinci sulfas anhydricus 6.45 mg ut zinci sulfas heptahydricum, aqua ad iniectabilia q.s. ad solutionem pro 500 ml. iii) fettemulsion: triglycerida 37.6 g, phospholipida purificata ex ovo, glycerolum 4.136 g, aqua ad iniectabilia q.s. ad emulsionem pro 188 ml. i) et ii) et iii) corresp.: aminoacida 51 g/l, carbohydrata 127 g/l, materia crassa - parenterale ernährung - synthetika human

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum monohydricum, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum dihydricum, natrii glycerophosphas, magnesii sulfas heptahydricus, kalii chloridum, natrii acetas trihydricus, zinci sulfas heptahydricum, triglycerida saturata media, aminoacida, materia crassa, carbohydrata, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum - infusionsemulsion - i) glucose-lösung 13%: glucosum monohydricum 71 g, aqua ad iniectabilia q.s. ad solutionem pro 544 ml. ii) aminosäurenlösung 10 % mit elektrolyten: alaninum 4.4 g, argininum 3.8 g, glycinum 3.5 g, histidinum 930 mg, isoleucinum 1.6 g, leucinum 2.3 g, lysinum anhydricum 2.1 g ut lysini acetas, methioninum 1.3 g, phenylalaninum 1.6 g, prolinum 3.5 g, serinum 2.1 g, taurinum 320 mg, threoninum 1.4 g, tryptophanum 630 mg, tyrosinum 120 mg, valinum 2 g, calcii chloridum dihydricum 180 mg, natrii glycerophosphas 1.3 g, magnesii sulfas heptahydricus 380 mg, kalii chloridum 1.4 g, natrii acetas trihydricus 1.1 g, zinci sulfas heptahydricum 4 mg, acidum aceticum ad ph, aqua ad iniectabilia q.s. ad solutionem pro 315 ml. iii) fettemulsion 20%: triglycerida saturata media 28 g, phospholipida purificata ex ovo, glycerolum, natrii hydroxidum ad ph, aqua ad iniectabilia q.s. ad emulsionem pro 141 ml. i) et ii) et iii) corresp.: aminoacida 31.5 g/l, materia crassa 28 g/l, carbohydrata 71 g/l, mineralia: natrium 25 mmol/l, k - periphervenöse parenterale ernährung - synthetika human

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum, sojae oleum raffinatum, triglycerida media, olivae oleum raffinatum, piscis oleum, aminoacida, nitrogenia, carbohydrata, materia crassa, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum, acetas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum anhydricum, natrii glycerophosphas, magnesii sulfas anhydricus, kalii chloridum, natrii acetas, zinci sulfas anhydricus - infusionsemulsion 493 ml - i) glucoselösung 42 %: glucosum 62.5 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 149 ml. ii) aminosäurenlösung mit elektrolyte: alaninum 3.5 g, argininum 3 g, glycinum 2.8 g, histidinum 0.8 g, isoleucinum 1.3 g, leucinum 1.9 g, lysinum anhydricum 1.7 g ut lysini acetas, methioninum 1.1 g, phenylalaninum 1.3 g, prolinum 2.8 g, serinum 1.6 g, taurinum 250 mg, threoninum 1.1 g, tryptophanum 0.5 g, tyrosinum 100 mg, valinum 1.6 g, calcii chloridum anhydricum 140 mg ut calcii chloridum dihydricum, natrii glycerophosphas 1.1 g, magnesii sulfas anhydricus 300 mg ut magnesii sulfas heptahydricus, kalii chloridum 1.1 g, natrii acetas 900 mg ut natrii acetas trihydricus, zinci sulfas anhydricus 3.3 mg ut zinci sulfas heptahydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 250 ml. iii) fettemulsion: sojae oleum raffinatum 5.6 g, triglycerida media 5.6 g, olivae oleum raffinatum 4.7 g, piscis oleum 2.8 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 94 ml. . i) et ii) et iii) corresp.: aminoacida 25 g, nitrogenia 4 g, carbohydrata 62.5 g, materia crassa 19 g, natrium 20 mmol, kalium 15 mmol, magnesium 2.5 mmol, calcium 1.3 mmol, phosphas 6 mmol, zincum 0.02 mmol, sulfas 2.5 mmol, chloridum 18 mmol, acetas 52 mmol, in emulsione recenter mixta 493 ml. corresp. 2300 kj pro 493 ml. - la nutrition parentérale - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

fresenius kabi (schweiz) ag - glucosum anhydricum, triglycerida saturata media, olivae oleum raffinatum, piscis oleum, aminoacida, nitrogenia, carbohydrata, materia crassa, acetas, phosphas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum - infusionsemulsion 1970 ml - i) glucoselösung 42 %: glucosum anhydricum 250 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 595 ml. ii) aminosäurenlösung: alaninum 14 g, argininum 12 g, glycinum 11 g, histidinum 3 g, isoleucinum 5 g, leucinum 7.4 g, lysinum anhydricum 6.6 g ut lysini acetas, methioninum 4.3 g, phenylalaninum 5.1 g, prolinum 11.2 g, serinum 6.5 g, taurinum 1 g, threoninum 4.4 g, tryptophanum 2 g, tyrosinum 400 mg, valinum 6.2 g, aqua ad iniectabilia q.s. ad solutionem pro 1000 ml. iii) fettemulsion: sojae oleum raffinatum, triglycerida saturata media 22.5 g, olivae oleum raffinatum 18.8 g, piscis oleum 11.3 g, int-rac-alfa-tocopherolum, phospholipida purificata ex ovo, glycerolum, natrii oleas, aqua ad iniectabilia q.s. ad emulsionem pro 375 ml. . i) et ii) et iii) corresp.: aminoacida 100 g, nitrogenia 16 g, carbohydrata 250 g, materia crassa 75 g, acetas 147 mmol, phosphas 5.6 mmol, in emulsione recenter mixta 1970 ml. corresp. 9200 kj pro 1970 ml. - parenterale ernährung für erwachsene - synthetika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

usz - zentrum für radiopharmazie, nuklearmedizin - fludeoxyglucosum(18-f) zum kalibrierungszeitpunkt - solution injectable - fludeoxyglucosum(18-f) zum kalibrierungszeitpunkt 0.1-8 gbq, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii chloridum, antiox.: natrii thiosulfas 1.3-1.9 mg, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - pet-tomographie - radiopharmazeutika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

swan isotopen ag - fludeoxyglucosum(18f) zum kalibrierungszeitpunkt - solution injectable - fludeoxyglucosum(18f) zum kalibrierungszeitpunkt 185 mbq, natrii chloridum, natrium 3.54 mg, ethanolum 5 µl, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - pet-tomographie - radiopharmazeutika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

universitätsspital zürich - fludeoxyglucosum(18f) - solution injectable i. v. application - fludeoxyglucosum(18f) 500-5000 mbq, natrii dihydrogenophosphas dihydricus corresp. natrium 1.95 mg, ethanolum 2 - 5 mg, aqua q.s. ad solutionem pro 1 ml. - pet-tomographie - radiopharmazeutika

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

swan isotopen ag - fludeoxyglucosum(18f) zum kalibrierungszeitpunkt - solution injectable - fludeoxyglucosum(18-f) zum kalibrierungszeitpunkt 185 mbq, natrii chloridum, ethanolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - pet-tomographie - radiopharmazeutika